Skip to main content

IB Acquisition Corp.

corporate_fare Company Profile

IB Acquisition Corp.

IBAC·NASDAQ·Industrial Applications And Services·CIK 0001998781

Our Company is a blank check company, initially formed in Delaware on July 7, 2020, and converted to a Nevada corporation on September 21, 2023. The company's purpose is to complete a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. While not sector-specific, the management team and board members identify compelling investment opportunities in consumer goods, sports and entertainment, and healthcare technology. The company anticipates targeting businesses domiciled in North America, Europe, and Asia, with an enterprise value of at least $500 million. The management team and board of directors possess significant experience in private investing, corporate finance and restructuring, and executive management across various industries. Their collective network spans North and South America, Asia-Pacific, and Europe. Key members include Adelmo "Al" Lopez, Chairman and Chief Executive Officer, who founded Alma Coffee and previously served as President and CEO of Blair Corporation and CFO of Dole Fresh Fruit International. Christy Albeck, Chief Financial Officer, founded and is Managing Member of Albeck Advisors, a consulting firm, and was previously Founder and CEO of Albeck Financial Services.

IB Acquisition Corp. (NASDAQ:IBAC) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 16 items for IBAC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-04, rated 7/10. Across its 16 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for IBAC spans DEF 14A, PRE 14A, 10-Q, S-4.

Recent high-impact activity:

  • IB Acquisition Sets Sept 24 Vote on Six-Month SPAC Deadline Extension
  • IB Acquisition Seeks Six-Month Extension to Complete GNQ Insilico Merger
  • IB Acquisition Corp. Reports Going Concern Warning and Ineffective Controls
  • IBAC Files S-4 for $500M Merger with AI Drug Discovery Firm GNQ Insilico
  • IB Acquisition Corp. Reports Q1 Loss, Confirms Merger Progress and Bridge Financing

Financial Snapshot

Fiscal year ended September 30, 2025
Net Income
$3.42M
Op. Cash Flow
-$1.32M
Operating Income
-$748.91K
Cash & Equivalents
$428.7K
Debt / Equity
0.00×
Shares Outstanding
4.25M sh
Source: 10-K · filed 2025-12-29 · accession 0001493152-25-029365
Browse all tickers starting with I →
$10.92 +0.01% today
52-week range · as of 2026-09-04 $10.19 – $11.45
Market cap
$54.69M
Volume
1.2K (0.7× avg)
3-mo avg 1.9K
Live data · 2026-09-14 03:17 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed IBAC - Latest Insights

IBAC
Sep 04, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $10.89
Real-time Price: $10.92 info
Change: +$0.030 (+0.28%) info
Market Cap: $54.69M info
IBAC
Aug 24, 2026, 5:48 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $10.81
Real-time Price: $10.92 info
Change: +$0.110 (+1%) info
Market Cap: $54.69M info
IBAC
Aug 14, 2026, 10:20 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $10.81
Real-time Price: $10.92 info
Change: +$0.110 (+1%) info
Market Cap: $54.69M info
IBAC
Jul 27, 2026, 9:07 AM EDT
Filing Type: S-4
Importance Score:
9
Price at Filing: $10.79
Real-time Price: $10.92 info
Change: +$0.130 (+1%) info
Market Cap: $54.69M info
IBAC
May 15, 2026, 4:11 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $10.76
Real-time Price: $10.92 info
Change: +$0.165 (+2%) info
Market Cap: $54.69M info
IBAC
May 15, 2026, 4:05 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $10.76
Real-time Price: $10.92 info
Change: +$0.165 (+2%) info
Market Cap: $54.69M info
IBAC
Apr 17, 2026, 5:28 PM EDT
Filing Type: 425
Importance Score:
9
Price at Filing: $10.76
Real-time Price: $10.92 info
Change: +$0.160 (+1%) info
Market Cap: $54.69M info
IBAC
Mar 27, 2026, 4:23 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $10.66
Real-time Price: $10.92 info
Change: +$0.260 (+2%) info
Market Cap: $54.69M info
IBAC
Mar 26, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $10.80
Real-time Price: $10.92 info
Change: +$0.120 (+1%) info
Market Cap: $54.69M info
IBAC
Mar 18, 2026, 1:57 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $10.70
Real-time Price: $10.92 info
Change: +$0.220 (+2%) info
Market Cap: $54.69M info
IBAC
Mar 16, 2026, 4:06 PM EDT
Filing Type: 425
Importance Score:
9
Price at Filing: $10.74
Real-time Price: $10.92 info
Change: +$0.180 (+2%) info
Market Cap: $54.69M info
IBAC
Mar 16, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $10.74
Real-time Price: $10.92 info
Change: +$0.180 (+2%) info
Market Cap: $54.69M info
IBAC
Mar 16, 2026, 1:45 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $10.72
Real-time Price: $10.92 info
Change: +$0.196 (+2%) info
Market Cap: $54.69M info
IBAC
Feb 23, 2026, 10:00 AM EST
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $10.69
Real-time Price: $10.92 info
Change: +$0.230 (+2%) info
Market Cap: $54.69M info
IBAC
Feb 12, 2026, 4:30 PM EST
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $10.60
Real-time Price: $10.92 info
Change: +$0.320 (+3%) info
Market Cap: $54.69M info
IBAC
Feb 11, 2026, 4:06 PM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $10.55
Real-time Price: $10.92 info
Change: +$0.370 (+4%) info
Market Cap: $54.69M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets